Impax Agrees to Settle Flomax Patent Dispute
Impax announced the settlement Wednesday, saying that the agreement will give Impax the opportunity to launch a generic version of Flomax on March 2, 2010, before the expiration of pediatric exclusivity. Additional terms of the settlement were confidential, Impax said.
A spokeswoman for Boehringer Ingelheim confirmed...
To view the full article, register now.